BCL2 and lung cancer: Moreover, a comparative analysis revealed that the treatment with RJ and the combination of RJ and AVE resulted in decreased levels of the antiapoptotic protein BCL-2 relative to the pro-apoptotic protein BAX in lung cancer cells.